These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3188045)

  • 1. An overview of structure-activity relationships as an alternative to testing in animals for carcinogenicity, mutagenicity, dermal and eye irritation, and acute oral toxicity.
    Enslein K
    Toxicol Ind Health; 1988 Dec; 4(4):479-98. PubMed ID: 3188045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of aliphatic amines: structure-activity relationship.
    Greim H; Bury D; Klimisch HJ; Oeben-Negele M; Ziegler-Skylakakis K
    Chemosphere; 1998 Jan; 36(2):271-95. PubMed ID: 9569935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro methods and safety testing of chemicals].
    Louekari K; Salminen L; Tähti H
    Duodecim; 1998; 114(9):851-8. PubMed ID: 11524804
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical diversity approach for evaluating mechanistic relatedness among toxicological phenomena.
    Pollack N; Cunningham AR; Klopman G; Rosenkranz HS
    SAR QSAR Environ Res; 1999 Dec; 10(6):533-43. PubMed ID: 10674291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR genotoxicity and tumorigenicity predictions for 2-MI and 4-MI using multiple SAR software.
    Krishna KA; Goel S; Krishna G
    Toxicol Mech Methods; 2014 May; 24(4):284-93. PubMed ID: 24401039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays.
    Benigni R; Bossa C; Tcheremenskaia O; Giuliani A
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):809-19. PubMed ID: 20438313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative methods for eye and skin irritation tests: an overview.
    Vinardell MP; Mitjans M
    J Pharm Sci; 2008 Jan; 97(1):46-59. PubMed ID: 17701961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a decision support system for the introduction of alternative methods into local irritancy/corrosivity testing strategies. Creation of fundamental rules for a decision support system.
    Gerner I; Zinke S; Graetschel G; Schlede E
    Altern Lab Anim; 2000; 28(5):665-98. PubMed ID: 11091765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology.
    Benigni R; Bossa C
    Mutat Res; 2008; 659(3):248-61. PubMed ID: 18621573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives to animal testing in the safety evaluation of products.
    Knight DJ; Breheny D
    Altern Lab Anim; 2002; 30(1):7-22. PubMed ID: 11827567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comments on the LD50 and acute eye and skin irritation tests. The Animals in Research Committee of the Society of Toxicology and approved by the SOT Council.
    Fundam Appl Toxicol; 1989 Nov; 13(4):621-3. PubMed ID: 2620785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics.
    Int J Toxicol; 2005; 24 Suppl 2():21-50. PubMed ID: 16154914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECVAM and new technologies for toxicity testing.
    Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
    Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the number of EINECS compounds that can be covered by (Q)SAR models for acute toxicity.
    Zvinavashe E; Murk AJ; Rietjens IM
    Toxicol Lett; 2009 Jan; 184(1):67-72. PubMed ID: 19041378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rodent carcinogenicity and toxicity, in vitro mutagenicity, and their physical chemical determinants.
    Benigni R; Andreoli C
    Mutat Res; 1993 Oct; 297(3):281-92. PubMed ID: 7692274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on the application of (Q)SAR to the toxicological evaluation of existing chemicals.
    Pölloth C; Mangelsdorf I
    Chemosphere; 1997 Dec; 35(11):2525-42. PubMed ID: 9394448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.